Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study

about

Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study

Item

http://www.wikidata.org/entity/Q56890364

description

scientific article published on 03 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Factors associated with the ac ...... ritis: the ANSWER cohort study

@en

Factors associated with the ac ...... ritis: the ANSWER cohort study

@nl

type

Item

label

Factors associated with the ac ...... ritis: the ANSWER cohort study

@en

Factors associated with the ac ...... ritis: the ANSWER cohort study

@nl

prefLabel

Factors associated with the ac ...... ritis: the ANSWER cohort study

@en

Factors associated with the ac ...... ritis: the ANSWER cohort study

@nl

P1476

Factors associated with the ac ...... ritis: the ANSWER cohort study

@en

P2093

Akira Ohnishi

http://www.w3.org/2001/XMLSchema#string

Hideki Amuro

http://www.w3.org/2001/XMLSchema#string

Hiromu Ito

http://www.w3.org/2001/XMLSchema#string

Kengo Akashi

http://www.w3.org/2001/XMLSchema#string

Koichiro Ohmura

http://www.w3.org/2001/XMLSchema#string

Koji Nagai

http://www.w3.org/2001/XMLSchema#string

Kosuke Ebina

http://www.w3.org/2001/XMLSchema#string

Masaki Katayama

http://www.w3.org/2001/XMLSchema#string

Masao Tanaka

http://www.w3.org/2001/XMLSchema#string

Moritoshi Furu

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis

Biologics registers in RA: methodological aspects, current role and future applications.

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period.

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study.

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.

Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values

P2888

s13075-018-1673-1

P304

165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-018-1673-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Motomu Hashimoto

P577

2018-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105981030

http://www.w3.org/2001/XMLSchema#string

P698

30075810

http://www.w3.org/2001/XMLSchema#string

P932

6091083

http://www.w3.org/2001/XMLSchema#string